INNOSTAR ORD A (SHH) EQSW Exp:
Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally. The company offers screening and discovery, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutics, radiopharmaceuticals, and traditional Chinese medicines. The company was founded in 2010 and is … Read more
INNOSTAR ORD A (SHH) EQSW Exp: (688710) - Total Assets
Latest total assets as of June 2025: CN¥3.21 Billion CNY
Based on the latest financial reports, INNOSTAR ORD A (SHH) EQSW Exp: (688710) holds total assets worth CN¥3.21 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
INNOSTAR ORD A (SHH) EQSW Exp: - Total Assets Trend (2021–2024)
This chart illustrates how INNOSTAR ORD A (SHH) EQSW Exp:’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
INNOSTAR ORD A (SHH) EQSW Exp: - Asset Composition Analysis
Current Asset Composition (December 2024)
INNOSTAR ORD A (SHH) EQSW Exp:'s total assets of CN¥3.21 Billion consist of 67.3% current assets and 32.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 42.5% |
| Accounts Receivable | CN¥268.19 Million | 8.3% |
| Inventory | CN¥332.02 Million | 10.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥105.52 Million | 3.3% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how INNOSTAR ORD A (SHH) EQSW Exp:'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: INNOSTAR ORD A (SHH) EQSW Exp:'s current assets represent 67.3% of total assets in 2024, a decrease from 69.7% in 2021.
- Cash Position: Cash and equivalents constituted 42.5% of total assets in 2024, up from 35.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 10.3% of total assets.
INNOSTAR ORD A (SHH) EQSW Exp: Competitors by Total Assets
Key competitors of INNOSTAR ORD A (SHH) EQSW Exp: based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Novartis AG
PINK:NVSEF
|
USA | $115.49 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $208.73 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $133.96 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $29.44 Billion |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥3.03 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
INNOSTAR ORD A (SHH) EQSW Exp: - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - INNOSTAR ORD A (SHH) EQSW Exp: generates 0.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, INNOSTAR ORD A (SHH) EQSW Exp: generates $ 4.59 in net profit.
INNOSTAR ORD A (SHH) EQSW Exp: - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.38 | 2.60 | 2.60 |
| Quick Ratio | 2.80 | 2.03 | 2.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.57 Billion | CN¥ 1.06 Billion | CN¥ 1.06 Billion |
INNOSTAR ORD A (SHH) EQSW Exp: - Advanced Valuation Insights
This section examines the relationship between INNOSTAR ORD A (SHH) EQSW Exp:'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 16.0% |
| Total Assets | CN¥3.22 Billion |
| Market Capitalization | $77.24K USD |
Valuation Analysis
Below Book Valuation: The market values INNOSTAR ORD A (SHH) EQSW Exp:'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: INNOSTAR ORD A (SHH) EQSW Exp:'s assets grew by 16.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for INNOSTAR ORD A (SHH) EQSW Exp: (2021–2024)
The table below shows the annual total assets of INNOSTAR ORD A (SHH) EQSW Exp: from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.22 Billion | +16.00% |
| 2023-12-31 | CN¥2.78 Billion | +6.00% |
| 2022-12-31 | CN¥2.62 Billion | +45.25% |
| 2021-12-31 | CN¥1.80 Billion | -- |